2020
DOI: 10.1007/s00018-020-03457-3
|View full text |Cite
|
Sign up to set email alerts
|

Founder cells for hepatocytes during liver regeneration: from identification to application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 84 publications
0
4
0
Order By: Relevance
“…In their experiments, Faber and colleagues observed mitosis in the small bile ducts and hyperplasia of the oval cells after ethionine diet (Farber, 1956). Subsequent studies suggested that the activity of these progenitor cells were mainly present at the canal of Hering and were involved in bi-potent activity, by replacing both damage hepatocytes and cholangiocytes (Wei et al, 2020). Although there are differences in the phenotypic markers between the HLSCs and oval cells, we can only speculate that HLSCs are a separate niche of stem cells in the liver, since it has not been confirmed in vivo.…”
Section: Hlsc Isolation and Characterizationmentioning
confidence: 85%
See 2 more Smart Citations
“…In their experiments, Faber and colleagues observed mitosis in the small bile ducts and hyperplasia of the oval cells after ethionine diet (Farber, 1956). Subsequent studies suggested that the activity of these progenitor cells were mainly present at the canal of Hering and were involved in bi-potent activity, by replacing both damage hepatocytes and cholangiocytes (Wei et al, 2020). Although there are differences in the phenotypic markers between the HLSCs and oval cells, we can only speculate that HLSCs are a separate niche of stem cells in the liver, since it has not been confirmed in vivo.…”
Section: Hlsc Isolation and Characterizationmentioning
confidence: 85%
“…Cell therapy is an alternative form of treatment for liver disease that involves in vitro amplification followed by transplantation of healthy stem/progenitor cells into patients, ideally through a minimally invasive procedure (Wei et al, 2020). Currently, many clinical trials of stem cell-based therapies for liver diseases have been carried out or are ongoing, including MSCs, hematopoietic stem cells, and other bone-marrow derived cells (Wei et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The lack of transplantable organs represents one of the most important problems in the field of transplantation, thus the development of regenerative medicine caught the attention of the scientific community. The liver has a high regenerative capability, and, consequently, it is a proper candidate for regenerative therapy [378]. Liver organoids have the capability to imitate hepatocyte regeneration during liver homeostasis, and they are gaining importance in the field of regenerative medicine, being considered as biological alternatives for organ replacement [379].…”
Section: Livermentioning
confidence: 99%